Evidence map›Paper›PMID 29512852›Full record

ReviewJournal of neuroendocrinology2018

Purinergic receptor types in the hypothalamic-neurohypophysial system.

José R Lemos, Edward E Custer, Sonia Ortiz-Miranda

Abstract readReview
In one paragraph

Review in Journal of neuroendocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

José R LemosMaPS.
Edward E CusterMaPS.
Sonia Ortiz-MirandaNeurobiology Depts. & Prog. Neurosci., Univ. Mass. Med. School, Worcester, MA 01605.
University of Massachusetts Chan Medical School · US

Funding

DEPOLARIZATION/SECRETION COUPLING IN NERVE TERMINALSR01NS029470 · NINDS · WORCESTER FOUNDATION FOR BIOMEDICAL RES · PI LEMOS, JOSE R · 1991 to 2012
$4.3M
Depolarization-secretion couplingR01NS093384 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ORTIZ-MIRANDA, SONIA · 2016 to 2018
$1.1M
Depolarization-secretion couplingR56NS093384 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LEMOS, JOSE R · 2015 to 2015
$419k
NINDS NIH HHS R01 NS029470NINDS NIH HHS R01 NS093384NINDS NIH HHS R56 NS093384
6 · The paper itself

Abstract

Many different types of purinergic receptors are present in the Hypothalamic-Neurohypophysial System (HNS), which synthesizes and releases vasopressin and oxytocin. The specific location of purinergic receptor subtypes has important functional repercussions for neuronal activity and synaptic output. Yet, until the advent of receptor KOs, this had been hindered by the low selectivity of the available pharmacological tools. The HNS offers an excellent opportunity to differentiate the functional properties of these purinergic receptors in cell bodies vs. terminals of the same physiological system. P2X2, P2X3, P2X4 and P2X7 receptors are present in vasopressin terminals while oxytocin terminals exclusively express the P2X7 subtype. The latter is not functional in the cell bodies of the HNS. These purinergic receptor subtypes are permeable to sodium vs. calcium in varying amounts and this could play an important role in the release of vasopressin vs. oxytocin during bursting activity. Endogenous ATP and its metabolite, adenosine, have autocrine and paracrine modulatory effects on the release of these neuropeptides during physiological stimulation. Finally, we hypothesize that during such action potential bursts, ATP potentiates the release of vasopressin but not of oxytocin, and that adenosine, via A1 receptors, inhibits the release of both neuropeptides. This article is protected by copyright. All rights reserved.

Indexed as

AdenosineA receptorsATPOxytocin (OT)P2X receptorsVasopressin (AVP)

Identifiers

PMID29512852
PMCPMC6128781
OpenAlexW2789936106

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.